Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Symptoms typically last for several hours [198,199,200,201,202]
Research shows they can lead to weight loss of about 10.5 to 15.8 pounds
When used with insulin or sulfonylureas, there is an increased risk of hypoglycaemia, and dose reduction of these medications may be needed
Variants in GIPR (the GIP receptor tirzepatide also activates), FTO, MC4R, and TCF7L2 are associated with measurably different response patterns
Aetnas typical PA requirements for Wegovy and Zepbound include: Documented BMI of 30 or higher, or BMI of 27 or higher with at least one weight-related comorbidity (type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea) Evidence of participation in a structured weight management program (diet, exercise, behavioral counseling) for a minimum period often 3 to 6 months Documentation that other weight loss interventions have been attempted Prescriber must be a physician, NP, or PA with appropriate prescribing authority Prior authorization is not a denial it is a documentation requirement
US$ 28.35
US$ 27.15
US$ 22.11
